News

UK-based BP is a manufacturer of self adhesive labels for the pharmaceutical, healthcare, cosmetic and food & drink markets, often providing them as part of an authentication solution.

The study, Horizon III, assessed the efficacy of Cediranib compared with Bevacizumab, both in combination with chemotherapy. Clinical activity was observed in the Cediranib arm of the study

Reportedly, the collaboration spans a range of research projects. Thomas Jensen, founder and CEO of Intomics, said: “We are extremely pleased to be working with LEO Pharma on

Cros NT said that Estimate, which has expertise and a particular excellence concerning the oncology and dermatology-related research, would enrich it. Estimate, found in 1992, is a privately

The studies were presented at the American Society of Clinical Oncology’s (ASCO) Genitourinary (GU) Cancers Symposium in San Francisco. In the two studies, PCA3 was used to test

The goal of the research collaboration is to demonstrate whether genomic sequencing of cancer tissue can provide clues for treatment strategies for these individuals. The research study brings

However, both companies will continue to collaborate in the field of prostate cancer. Loic Maurel, president of management board at ExonHit, said: “ExonHit’s technology was able to produce

Spray drying is an important technology to improve the bioavailability of poorly soluble APIs. The spray drying technology can be applied in pharmaceutical production to obtain several benefits

The PTO, for the second time, has denied all claims under consideration as lacking novelty and/or as obvious in view of a variety of references, including many that